| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20K | +41.7% | -80.1% |
| SG&A Expense | $270K | -29.6% | +10.7% |
| Interest Expense | $960 | +0.0% | +0.0% |
| Net Income | -$569K | +12.4% | +11.7% |
| EPS (Basic) | -$0.03 | +11.8% | +25.0% |
| EPS (Diluted) | -$0.03 | +11.8% | +25.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $92 | -89.0% | -99.9% |
| Total Assets | $7K | -16.5% | -92.1% |
| Current Liabilities | $2.2M | +9.6% | +12.3% |
| Total Liabilities | $2.2M | +9.6% | +12.2% |
| Stockholders' Equity | -$2.2M | -9.7% | -17.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$430K | — | — |
| Financing Cash Flow | $424K | — | — |